• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

@rachel

Profile

Registered: 13 years ago


Forums

Topics Started: 2

Replies Created: 0

Forum Role: Keymaster

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 20
7:45 am - 5:15 pm MST

Canadian Society of Palliative Medicine: Palliative Horizons – Clinical Approaches to ALS and Parkinson’s

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Jean

    Jean
    jean

  • Frank Taylor, USA

    Frank Taylor, USA

  • Alex, Argentina

    Alex, Argentina

  • Mark Miller, UK

    Mark Miller, UK

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Denis Blais, Canada

    Denis Blais, Canada

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Purningam Jacob, India

    Purningam Jacob, India

  • Zabun Nassar, England

    Zabun Nassar, England

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Anna Barrow, UK

    Anna Barrow, UK

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Michael Lee, Australia

    Michael Lee, Australia

  • David Solomon, UK

    David Solomon, UK

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Phil Rossall, UK

    Phil Rossall, UK

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Glen Elison, USA

    Glen Elison, USA

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login